Literature DB >> 29129256

Instantaneous wave-free ratio and fractional flow reserve for the assessment of nonculprit lesions during the index procedure in patients with ST-segment elevation myocardial infarction: The WAVE study.

Carmine Musto1, Francesco De Felice2, Stefano Rigattieri3, Diana Chin2, Andrea Marra2, Marco Stefano Nazzaro2, Alberta Cifarelli2, Roberto Violini2.   

Abstract

BACKGROUND: Functional assessment of non-infarct-related artery lesions during primary percutaneous coronary intervention (PCI) might be useful to avoid revascularization of nonsignificant stenosis and staged procedures, thus reducing hospital stay. We aimed to assess the diagnostic performance of instantaneous wave-free ratio (iFR) as compared with fractional flow reserve (FFR) in this setting.
METHODS: In the WAVE study, a prospective, observational, single-center registry (NCT02869906), paired iFR and FFR measurements were performed at the level of non-IRA lesions in patients with ST-segment elevation myocardial infarction both during primary PCI and during staged procedures (5-8 days after).
RESULTS: Paired iFR and FFR measurements were available for 66 non-IRA lesions in 50 patients. The iFR and FFR values of non-IRA lesions did not change significantly between the index and staged procedure. Bland-Altman analysis did not show systematic bias for either iFR or FFR repeated measures. Receiver operating characteristic curve analysis showed high accuracy of iFR to identify positive (≤0.80) FFR measurements in the index procedure with an area under the curve of 0.95. A cutoff of ≤0.89 for iFR in the index procedure had the best combination of sensitivity (95%) and specificity (90%) with positive and negative predictive values of 86% and 97%, respectively. Finally, iFR measured during the index procedure was significantly correlated with FFR (r=0.71, r2=0.51; P<.0001).
CONCLUSIONS: The WAVE study shows that iFR yields similar diagnostic accuracy to FFR in functional evaluation of non-IRA stenosis in patients with STEMI and multivessel CAD, with the advantage of being adenosine free.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29129256     DOI: 10.1016/j.ahj.2017.07.017

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Feasibility and diagnostic reliability of quantitative flow ratio in the assessment of non-culprit lesions in acute coronary syndrome.

Authors:  Aslihan Erbay; Lisa Penzel; Youssef S Abdelwahed; Jens Klotsche; Anne-Sophie Schatz; Julia Steiner; Arash Haghikia; Ulf Landmesser; Barbara E Stähli; David M Leistner
Journal:  Int J Cardiovasc Imaging       Date:  2021-03-02       Impact factor: 2.357

Review 2.  Why, When and How Should Clinicians Use Physiology in Patients with Acute Coronary Syndromes?

Authors:  Roberto Scarsini; Dimitrios Terentes-Printzios; Giovanni Luigi De Maria; Flavio Ribichini; Adrian Banning
Journal:  Interv Cardiol       Date:  2020-06-04

3.  Fractional flow reserve in acute coronary syndrome: a meta-analysis and systematic review.

Authors:  Kevin P Liou; Sze-Yuan M Ooi; Stephen P Hoole; Nick E J West
Journal:  Open Heart       Date:  2019-01-13

4.  Agreement between nonculprit stenosis follow-up iFR and FFR after STEMI (iSTEMI substudy).

Authors:  Troels Thim; Matthias Götberg; Ole Fröbert; Robin Nijveldt; Niels van Royen; Sergio Bravo Baptista; Sasha Koul; Thomas Kellerth; Hans Erik Bøtker; Christian Juhl Terkelsen; Evald Høj Christiansen; Lars Jakobsen; Steen Dalby Kristensen; Michael Maeng
Journal:  BMC Res Notes       Date:  2020-09-01

5.  Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data.

Authors:  Frederik M Zimmermann; Elmir Omerovic; Stephane Fournier; Henning Kelbæk; Nils P Johnson; Martina Rothenbühler; Panagiotis Xaplanteris; Mohamed Abdel-Wahab; Emanuele Barbato; Dan Eik Høfsten; Pim A L Tonino; Bianca M Boxma-de Klerk; William F Fearon; Lars Køber; Pieter C Smits; Bernard De Bruyne; Nico H J Pijls; Peter Jüni; Thomas Engstrøm
Journal:  Eur Heart J       Date:  2019-01-07       Impact factor: 29.983

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.